{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:13:58Z","timestamp":1778667238231,"version":"3.51.4"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005378","name":"Hacettepe \u00dcniversitesi","doi-asserted-by":"publisher","award":["5291"],"award-info":[{"award-number":["5291"]}],"id":[{"id":"10.13039\/501100005378","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.pbb.2025.174096","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:39:30Z","timestamp":1757540370000},"page":"174096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Autophagy activation ameliorates cognitive deficits and alpha-synuclein pathology in an adeno-associated viral vector mediated rat model of Lewy body disorders"],"prefix":"10.1016","volume":"257","author":[{"given":"Elif","family":"Cinar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcl","family":"Yalcin-Cakmakli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilal","family":"Akyel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse","family":"Ulusoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu Cahide","family":"Tel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00fclent","family":"Elibol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2025.174096_bb0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.pbb.2025.174096_bb0010","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1523\/JNEUROSCI.3047-16.2016","article-title":"Hippocampal alpha-synuclein in dementia with Lewy bodies contributes to memory impairment and is consistent with spread of pathology","volume":"37","author":"Adamowicz","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2025.174096_bb0015","article-title":"Rapamycin improves motor function, reduces 4-hydroxynonenal adducted protein in brain, and attenuates synaptic injury in a mouse model of synucleinopathy","volume":"5","author":"Bai","year":"2015","journal-title":"Pathobiol. Aging Age Relat. Dis."},{"key":"10.1016\/j.pbb.2025.174096_bb0020","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1007\/s12035-022-02851-1","article-title":"Exploring the role of ubiquitin-proteasome system in Parkinson\u2019s disease","volume":"59","author":"Behl","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pbb.2025.174096_bb0025","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev-biochem-060815-014556","article-title":"Mammalian autophagy: how does it work?","volume":"85","author":"Bento","year":"2016","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.pbb.2025.174096_bb0030","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrn3068","article-title":"Fighting neurodegeneration with rapamycin: mechanistic insights","volume":"12","author":"Bove","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pbb.2025.174096_bb0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pbb.2025.174096_bb0040","doi-asserted-by":"crossref","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","article-title":"Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and tau: effects on cognitive impairments","volume":"285","author":"Caccamo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbb.2025.174096_bb0045","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1523\/JNEUROSCI.0777-14.2014","article-title":"Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer\u2019s disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature","volume":"34","author":"Caccamo","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2025.174096_bb0050","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pbb.2025.174096_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113357","article-title":"Modelling cognitive deficits in Parkinson\u2019s disease: is CA2 a gateway for hippocampal synucleinopathy?","volume":"330","author":"Cinar","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pbb.2025.174096_bb0060","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/nan.12659","article-title":"Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer\u2019s disease","volume":"46","author":"Coughlin","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.pbb.2025.174096_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009313","article-title":"Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy","volume":"5","author":"Crews","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2025.174096_bb0070","doi-asserted-by":"crossref","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","article-title":"Pathogenic lysosomal depletion in Parkinson\u2019s disease","volume":"30","author":"Dehay","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2025.174096_bb0075","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.brainres.2016.10.008","article-title":"Beta-asarone improves learning and memory and reduces acetyl cholinesterase and Beta-amyloid 42 levels in APP\/PS1 transgenic mice by regulating Beclin-1-dependent autophagy","volume":"1652","author":"Deng","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2025.174096_bb0080","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/WNL.41.9.1402","article-title":"Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD","volume":"41","author":"Dickson","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2025.174096_bb0085","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41531-023-00574-1","article-title":"Hippocampal subfield vulnerability to alpha-synuclein pathology precedes neurodegeneration and cognitive dysfunction","volume":"9","author":"Dues","year":"2023","journal-title":"npj Parkinsons Dis."},{"key":"10.1016\/j.pbb.2025.174096_bb0090","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.molcel.2011.06.038","article-title":"p62 is a key regulator of nutrient sensing in the mTORC1 pathway","volume":"44","author":"Duran","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.pbb.2025.174096_bb0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/mdc3.13127","article-title":"Delineation of apathy subgroups in Parkinson\u2019s disease: differences in clinical presentation, functional ability, health-related quality of life, and caregiver burden","volume":"8","author":"Eglit","year":"2021","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.pbb.2025.174096_bb0100","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/leu.2014.19","article-title":"Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia","volume":"28","author":"El-Khoury","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.pbb.2025.174096_bb0105","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/mds.28480","article-title":"Involvement of autophagy in levodopa-induced dyskinesia","volume":"36","author":"Feyder","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pbb.2025.174096_bb0110","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/mds.26586","article-title":"H ippocampal \u03b1-synuclein and interneurons in P arkinson\u2019s disease: data from human and mouse models","volume":"31","author":"Flores-Cuadrado","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pbb.2025.174096_bb0115","doi-asserted-by":"crossref","first-page":"14241","DOI":"10.1074\/jbc.RA119.008733","article-title":"Autophagy activation promotes clearance of alpha-synuclein inclusions in fibril-seeded human neural cells","volume":"294","author":"Gao","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbb.2025.174096_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.626128","article-title":"Molecular mechanisms underlying synaptic and axon degeneration in Parkinson\u2019s disease","volume":"15","author":"Gcwensa","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pbb.2025.174096_bb0125","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.expneurol.2007.12.017","article-title":"Alpha-synuclein transgenic mice exhibit reduced anxiety-like behaviour","volume":"210","author":"George","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pbb.2025.174096_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081426","article-title":"Morphological and behavioral impact of AAV2\/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system","volume":"8","author":"Gombash","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2025.174096_bb0135","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1541-7786.MCR-12-0605","article-title":"Equivalent benefit of rapamycin and a potent mTOR ATP-competitive inhibitor, MLN0128 (INK128), in a mouse model of tuberous sclerosis","volume":"11","author":"Guo","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.pbb.2025.174096_bb0140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.expneurol.2007.07.006","article-title":"Human-based studies on alpha-synuclein deposition and relationship to Parkinson\u2019s disease symptoms","volume":"209","author":"Halliday","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pbb.2025.174096_bb0145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuroscience.2012.06.054","article-title":"Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice","volume":"223","author":"Halloran","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2025.174096_bb0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00702-021-02431-y","article-title":"Protein clearance strategies for disease intervention","volume":"129","author":"Hommen","year":"2022","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pbb.2025.174096_bb0155","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3892\/ijmm.2013.1280","article-title":"Rapamycin protects the mitochondria against oxidative stress and apoptosis in a rat model of Parkinson\u2019s disease","volume":"31","author":"Jiang","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.pbb.2025.174096_bb0160","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.neuron.2018.01.016","article-title":"Anxiety cells in a hippocampal-hypothalamic circuit","volume":"97","author":"Jimenez","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2025.174096_bb0165","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.yexcr.2014.08.001","article-title":"Raf\/MEK\/ERK can regulate cellular levels of LC3B and SQSTM1\/p62 at expression levels","volume":"327","author":"Kim","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.pbb.2025.174096_bb0170","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of \u03b1-synuclein in the nigrostriatal system","volume":"22","author":"Kirik","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2025.174096_bb0175","doi-asserted-by":"crossref","first-page":"10825","DOI":"10.1073\/pnas.152112399","article-title":"Reduced fear expression after lesions of the ventral hippocampus","volume":"99","author":"Kjelstrup","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pbb.2025.174096_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2020.1797280","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)(1)","volume":"17","author":"Klionsky","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.pbb.2025.174096_bb0185","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108863","article-title":"Autophagy in major human diseases","volume":"40","author":"Klionsky","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.pbb.2025.174096_bb0190","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75398","article-title":"Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2","volume":"11","author":"Kosillo","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.pbb.2025.174096_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-016-8417-7","article-title":"mTOR signaling in Parkinson\u2019s disease","volume":"19","author":"Lan","year":"2017","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.pbb.2025.174096_bb0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nlm.2016.11.006","article-title":"Rapamycin inhibits mTOR\/p70S6K activation in CA3 region of the hippocampus of the rat and impairs long term memory","volume":"137","author":"Lana","year":"2017","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.pbb.2025.174096_bb0205","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","article-title":"mTOR signaling at a glance","volume":"122","author":"Laplante","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.pbb.2025.174096_bb0210","article-title":"Targeted degradation of\u237a-synuclein aggregates in Parkinson\u2019s disease using the AUTOTAC technology","volume":"18","author":"Lee","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pbb.2025.174096_bb0215","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11064-012-0909-8","article-title":"Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice","volume":"38","author":"Liu","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pbb.2025.174096_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11658-016-0031-z","article-title":"p62 links the autophagy pathway and the ubiqutin\u2013proteasome system upon ubiquitinated protein degradation","volume":"21","author":"Liu","year":"2016","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.pbb.2025.174096_bb0225","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.4103\/1673-5374.371381","article-title":"Rapamycin reverses ferroptosis by increasing autophagy in MPTP\/MPP(+)-induced models of Parkinson\u2019s disease","volume":"18","author":"Liu","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.pbb.2025.174096_bb0230","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00401-018-1829-8","article-title":"Differential alpha-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity","volume":"135","author":"Luna","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pbb.2025.174096_bb0235","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1474-9726.2011.00791.x","article-title":"Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1beta and enhancing NMDA signaling","volume":"11","author":"Majumder","year":"2012","journal-title":"Aging Cell"},{"key":"10.1016\/j.pbb.2025.174096_bb0240","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1523\/JNEUROSCI.3944-09.2010","article-title":"Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson\u2019s disease","volume":"30","author":"Malagelada","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2025.174096_bb0245","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fneur.2018.00208","article-title":"Inhibition of mTORC1 signaling reverts cognitive and affective deficits in a mouse model of Parkinson\u2019s disease","volume":"9","author":"Masini","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pbb.2025.174096_bb0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-021-00273-9","article-title":"Lewy body disease or diseases with Lewy bodies?","volume":"8","author":"Mensikova","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.pbb.2025.174096_bb0255","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/brain\/awac087","article-title":"Striatal synaptic bioenergetic and autophagic decline in premotor experimental parkinsonism","volume":"145","author":"Merino-Galan","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.pbb.2025.174096_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2011.00051","article-title":"Striatal signaling in L-DOPA-induced dyskinesia: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation","volume":"5","author":"Murer","year":"2011","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.pbb.2025.174096_bb0265","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.nlm.2007.10.002","article-title":"On the participation of mTOR in recognition memory","volume":"89","author":"Myskiw","year":"2008","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.pbb.2025.174096_bb0270","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative disease","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.pbb.2025.174096_bb0275","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nbd.2008.06.003","article-title":"Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement","volume":"32","author":"Pan","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pbb.2025.174096_bb0280","article-title":"Autophagy in neurodegenerative diseases: a hunter for aggregates","volume":"21","author":"Park","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pbb.2025.174096_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070274","article-title":"Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson\u2019s disease","volume":"8","author":"Paumier","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2025.174096_bb0290","series-title":"The Rat Brain in Stereotaxic Coordinates: Hard Cover Edition","author":"Paxinos","year":"2006"},{"key":"10.1016\/j.pbb.2025.174096_bb0295","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.nbd.2015.03.014","article-title":"mTOR signaling in aging and neurodegeneration: at the crossroad between metabolism dysfunction and impairment of autophagy","volume":"84","author":"Perluigi","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pbb.2025.174096_bb0300","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/978-3-7091-0932-8_24","article-title":"Synaptic dysfunction in Parkinson\u2019s disease","volume":"970","author":"Picconi","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.pbb.2025.174096_bb0305","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10517-021-05242-z","article-title":"Restoration of Parkinson\u2019s disease-like deficits by activating autophagy through mTOR-dependent and mTOR-independent mechanisms in pharmacological and transgenic models of Parkinson\u2019s disease in mice","volume":"171","author":"Pupyshev","year":"2021","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.pbb.2025.174096_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105311","article-title":"mTOR signaling as a molecular target for the alleviation of Alzheimer\u2019s disease pathogenesis","volume":"155","author":"Rapaka","year":"2022","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pbb.2025.174096_bb0315","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12974-017-0793-x","article-title":"Neuroprotective effects of intrastriatal injection of rapamycin in a mouse model of excitotoxicity induced by quinolinic acid","volume":"14","author":"Saliba","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.pbb.2025.174096_bb0320","doi-asserted-by":"crossref","first-page":"ra36","DOI":"10.1126\/scisignal.2000308","article-title":"Inhibition of mTOR signaling in Parkinson\u2019s disease prevents L-DOPA\u2013induced dyskinesia","volume":"2","author":"Santini","year":"2009","journal-title":"Sci. Signal."},{"issue":"Suppl. 1","key":"10.1016\/j.pbb.2025.174096_bb0325","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.parkreldis.2015.09.027","article-title":"Non motor subtypes and Parkinson\u2019s disease","volume":"22","author":"Sauerbier","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pbb.2025.174096_bb0330","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000360925","article-title":"Anatomy of the hippocampal formation","volume":"34","author":"Schultz","year":"2014","journal-title":"Front. Neurol. Neurosci."},{"key":"10.1016\/j.pbb.2025.174096_bb0335","series-title":"The Synaptic Organization of the Brain","author":"Shepherd","year":"2003"},{"key":"10.1016\/j.pbb.2025.174096_bb0340","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5483\/BMBRep.2020.53.1.283","article-title":"The central regulator p62 between ubiquitin proteasome system and autophagy and its role in the mitophagy and Parkinson\u2019s disease","volume":"53","author":"Shin","year":"2020","journal-title":"BMB Rep."},{"key":"10.1016\/j.pbb.2025.174096_bb0345","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1007\/s12035-016-0129-3","article-title":"Neuroprotection through rapamycin-induced activation of autophagy and PI3K\/Akt1\/mTOR\/CREB signaling against amyloid-beta-induced oxidative stress, synaptic\/neurotransmission dysfunction, and neurodegeneration in adult rats","volume":"54","author":"Singh","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pbb.2025.174096_bb0350","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s12035-017-0496-4","article-title":"Neuroprotective effects of temsirolimus in animal models of Parkinson\u2019s disease","volume":"55","author":"Siracusa","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pbb.2025.174096_bb0355","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.parkreldis.2009.11.002","article-title":"Mild cognitive impairment in Parkinson\u2019s disease: subtypes and motor characteristics","volume":"16","author":"Sollinger","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pbb.2025.174096_bb0360","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3858\/emm.2012.44.2.031","article-title":"Neuronal autophagy and neurodegenerative diseases","volume":"44","author":"Son","year":"2012","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.pbb.2025.174096_bb0365","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1523\/JNEUROSCI.4390-09.2009","article-title":"Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson\u2019s and Lewy body diseases","volume":"29","author":"Spencer","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2025.174096_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009979","article-title":"Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer\u2019s disease","volume":"5","author":"Spilman","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2025.174096_bb0375","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-60761-756-3_13","article-title":"Measurement of autophagy in cells and tissues","volume":"648","author":"Tanida","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.pbb.2025.174096_bb0380","doi-asserted-by":"crossref","first-page":"15194","DOI":"10.1074\/jbc.M113.457408","article-title":"Lewy body-like alpha-synuclein aggregates resist degradation and impair macroautophagy","volume":"288","author":"Tanik","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbb.2025.174096_bb0385","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1021\/acs.jmedchem.3c00274","article-title":"Discovery of small-molecule degraders for alpha-synuclein aggregates","volume":"66","author":"Tong","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pbb.2025.174096_bb0390","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3233\/JPD-202465","article-title":"The human hippocampus in Parkinson\u2019s disease: an integrative stereological and proteomic study","volume":"11","author":"Villar-Conde","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.pbb.2025.174096_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-019-03013-x","article-title":"AAV2\/DJ-mediated alpha-synuclein overexpression in the rat substantia nigra as early stage model of Parkinson\u2019s disease","volume":"378","author":"von Hovel","year":"2019","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.pbb.2025.174096_bb0400","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/gerona\/glab142","article-title":"Rapamycin activates mitophagy and alleviates cognitive and synaptic plasticity deficits in a mouse model of Alzheimer\u2019s disease","volume":"76","author":"Wang","year":"2021","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.pbb.2025.174096_bb0405","doi-asserted-by":"crossref","first-page":"25009","DOI":"10.1074\/jbc.M300227200","article-title":"Alpha-synuclein is degraded by both autophagy and the proteasome","volume":"278","author":"Webb","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbb.2025.174096_bb0410","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.201003122","article-title":"Alpha-synuclein impairs macroautophagy: implications for Parkinson\u2019s disease","volume":"190","author":"Winslow","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.pbb.2025.174096_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-023-00614-w","article-title":"Aggregate-prone brain regions in Parkinson\u2019s disease are rich in unique N-terminus alpha-synuclein conformers with high proteolysis susceptibility","volume":"10","author":"Wiseman","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.pbb.2025.174096_bb0420","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26653","article-title":"Anatomical and functional organization of the human substantia nigra and its connections","volume":"6","author":"Zhang","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.pbb.2025.174096_bb0425","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.21037\/apm-20-1096","article-title":"Effects and potential mechanisms of rapamycin on MPTP-induced acute Parkinson\u2019s disease in mice","volume":"10","author":"Zhang","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.pbb.2025.174096_bb0430","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCRESAHA.111.244707","article-title":"Autophagy and p62 in cardiac proteinopathy","volume":"109","author":"Zheng","year":"2011","journal-title":"Circ. Res."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305725001431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305725001431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:30:46Z","timestamp":1778664646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305725001431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":86,"alternative-id":["S0091305725001431"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2025.174096","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autophagy activation ameliorates cognitive deficits and alpha-synuclein pathology in an adeno-associated viral vector mediated rat model of Lewy body disorders","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2025.174096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"174096"}}